Moltic Pharma

Business Data, Corporate Office and Headquarter Address

About

Moltic Pharma is Drug Discovery in Sweden that focus on owner business. Founded in 2017. They cover business area such as owner, operator, drug, epilepsy.

Business Type

Drug Discovery

Country

Sweden

Founded

2017
( 7 years old in 2024 )

Company Focus

Owner

Website

-

Corporate Office and Headquarter Office address:

Linköping
Sweden

Phone number:

Private

Office Opening Hours*:

Monday 9.30 - 17.00
Tuesday 9.30 - 17.00
Wednesday 9.30 - 17.00
Thursday 9.30 - 17.00
Friday 9.30 - 17.00
Saturday Closed
Sunday Closed

Business Coverage

owneroperatordrugepilepsy

* We use standard office opening hours in near Moltic Pharma's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.

Moltic Pharma Frequently Asked Questions

What or who is Moltic Pharma?

Moltic Pharma is Drug Discovery business from Sweden that founded in 2017 (7 years old in 2024), Moltic Pharma business is focusing on Owner.

Where is Moltic Pharma headquarter and corporate office address?

Moltic Pharma headquarter office and corporate office address is located in Linköping Sweden.

Where is Moltic Pharma country origins?

Moltic Pharma was founded in Sweden.

What is Owner business focus on?

In 2024, Moltic Pharma is currently focus on owner sector.

Owner Business Interest from Google Trend

Above is snippet of Google Trends for "owner" term, if you have problem loading the snippet, please visit here: Google Trend.

Disclaimer: This website is not affiliated with Moltic Pharma, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.